| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2023 | Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers | YI-JOU TAI ; CHUN-JU CHIANG ; YING-CHENG CHIANG ; CHIA-YING WU ; WEN-CHUNG LEE ; WEN-FANG CHENG | Scientific reports | | | |
| 2016 | Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; Cheng Y.-J.; Jen Y.-W.; CHI-AN CHEN ; WEN-FANG CHENG ; WEI-ZEN SUN | American Journal of Cancer Research | 9 | | |
| 2019 | Bevacizumab dose affects the severity of adverse events in gynecologic malignancies | Lee S.-P.; HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Frontiers in Pharmacology | 13 | 14 | |
| 2008 | 'Big-eyed frog' sign on spatiotemporal image correlation (STIC) in the antenatal diagnosis of transposition of the great arteries | JIN-CHUNG SHIH ; MING-KWANG SHYU ; Su Y.N; YING-CHENG CHIANG ; Lin C.H; CHIEN-NAN LEE | Ultrasound in Obstetrics and Gynecology | 19 | 11 | |
| 2019 | Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization | Sun N.-Y.; YU-LI CHEN ; Wu W.-Y.; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancers | 35 | 35 | |
| 2012 | Brain metastases from epithelial ovarian carcinoma: Evaluation of prognosis and managements - A Taiwanese Gynecologic Oncology Group (TGOG) Study | YING-CHENG CHIANG ; Qiu J.-T.; Chang C.-L.; Wang P.-H.; Ho C.-M.; Lin W.-C.; Huang Y.-F.; Lin H.; Lu C.-H.; Chou C.-Y. | Gynecologic Oncology | 13 | 13 | |
| 2018 | CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer | Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU ; Lin, Hsiu-Ping; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Epigenomics | 8 | 7 | |
| 2019 | CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells | Lin H.-W.; YING-CHENG CHIANG ; Sun N.-Y.; YU-LI CHEN ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 8 | 9 | |
| 2014 | Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations | Huang H.-N.; Huang W.-C.; CHING-HUNG LIN ; YING-CHENG CHIANG ; Huang H.-Y.; KUAN-TING KUO | Human Pathology | 16 | 20 | |
| 2012 | Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects | Chang M.-C.; CHIEN-NAN LEE ; YU-LI CHEN ; YING-CHENG CHIANG ; WEI-ZEN SUN ; Hu Y.-H.; CHI-AN CHEN ; WEN-FANG CHENG | Clinical Science | 11 | 11 | |
| 2022 | Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; I-CHUN CHEN ; Huang, Chia-Yen; CHI-AN CHEN ; YING-CHENG CHIANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 0 | 0 | |
| 2019 | Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model | TZU-PIN LU ; KUAN-TING KUO ; Chen, Ching-Hsuan; Chang, Ming-Cheng; Lin, Hsiu-Ping; Hu, Yu-Hao; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN | Cancers | 12 | 11 | |
| 2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 2 | 2 | |
| 2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 18 | 18 | |
| 2015 | Establishment of a New Ovarian Cancer Cell Line CA5171 | YING-CHENG CHIANG ; WEN-FANG CHENG ; Chang M.-C.; TZU-PIN LU ; KUAN-TING KUO ; Lin H.-P.; CHANG-YAO HSIEH ; CHI-AN CHEN | Reproductive Sciences | 5 | 6 | |
| 2021 | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors | Shen, Hung; HENG-CHENG HSU ; YI-JOU TAI ; KUAN-TING KUO ; CHIA-YING WU ; YEN-LING LAI ; YING-CHENG CHIANG ; YU-LI CHEN ; WEN-FANG CHENG | Frontiers in oncology | 4 | 4 | |
| 2018 | Factors predicting parametrial invasion in patients with early-stage cervical carcinomas | HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | PLoS ONE | 12 | 12 | |
| 2015 | Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas | CHI-AN CHEN ; YING-CHENG CHIANG ; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG | American Journal of Translational Research | 7 | | |
| 2016 | Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup | JEN-CHIEH LEE ; TZU-PIN LU ; Changou C.A.; Liang C.-W.; Huang H.-N.; Lauria A.; Huang H.-Y.; Lin C.-Y.; YING-CHENG CHIANG ; Davidson B.; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 21 | 20 | |
| 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 109 | 109 | |
